Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(6), P. 3537 - 3537
Published: March 21, 2024
Lipoprotein(a)
[Lp(a)]
consists
of
a
low-density
lipoprotein-like
molecule
and
an
apolipoprotein(a)
[apo(a)]
particle.
Lp(a)
has
been
suggested
to
be
independent
risk
factor
atherosclerotic
cardiovascular
disease
(ASCVD).
plasma
levels
are
considered
70–90%
genetically
determined
through
the
codominant
expression
LPA
gene.
Therefore,
almost
stable
during
individual’s
lifetime.
This
lifelong
stability,
together
with
difficulties
in
measuring
standardized
manner,
may
account
for
scarcity
available
drugs
targeting
Lp(a).
In
this
review,
we
synopsize
latest
data
regarding
structure,
metabolism,
factors
affecting
circulating
Lp(a),
as
well
laboratory
determination
measurement
its
role
pathogenesis
ASCVD
thrombosis,
potential
use
various
therapeutic
agents
particular,
discuss
novel
agents,
such
antisense
oligonucleotides
(ASOs)
small
interfering
RNAs
(siRNAs)
that
currently
being
developed
target
The
promising
muvalaplin,
oral
inhibitor
formation,
is
then
further
analyzed.
Language: Английский
Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(10), P. 1526 - 1526
Published: May 18, 2024
Long-term
exposure
to
even
slightly
elevated
plasma
cholesterol
levels
significantly
increases
the
risk
of
developing
cardiovascular
disease.
The
latest
evidence
recommends
an
improvement
in
lipid
levels,
children
who
are
not
affected
by
severe
hypercholesterolemia.
risk–benefit
profile
pharmacological
treatments
pediatric
patients
with
moderate
dyslipidemia
is
uncertain,
and
several
cholesterol-lowering
nutraceuticals
have
been
recently
tested.
In
this
context,
available
randomized
clinical
trials
small,
short-term
mainly
tested
different
types
fibers,
plant
sterols/stanols,
standardized
extracts
red
yeast
rice,
polyunsaturated
fatty
acids,
soy
derivatives,
some
probiotics.
dyslipidemia,
can
improve
context
adequate,
well-balanced
diet
combined
regular
physical
activity.
Of
course,
they
should
be
considered
alternative
conventional
lipid-lowering
drugs
when
necessary.
Language: Английский
Oxidative Stress, LDL-Cholesterol and Lipoprotein(a): A New Formula to Balance Two Diverging Culprits
Published: May 21, 2024
Atherosclerotic
cardiovascular
disease,
a
leading
cause
of
morbidity
and
mortality
worldwide,
is
chronic
inflammatory
linked
to
state
oxidative
stress,
with
several
well-identified
culprits,
which
low-density-lipoprotein
cholesterol
(LDL-C)
lipoprotein(a).
No
specific
treatment
currently
available
lower
It
is,
therefore,
paramount
importance
identify
nutritional
factors
that
could
Growing
evidence
shows
although
reducing
saturated
fatty
acid
(SFA)
intake
decreases
LDL-C,
it
increase
Optimal
dietary
recommendations
may
therefore
differ
depending
on
an
in-dividual’s
baseline
lipoprotein(a)
LDL-C
levels.
Assessing
the
diet-induced
true
response
net
balance
these
two
atherogenic
entities
difficult
because
measurement
confounded
by
content.
We
have
estimated,
for
first
time,
result
variations
both
lipoprotein(a),
thanks
our
new
concept
LDLapoB
risk
equivalent=apoB+lp(a)x5
(in
nmol/L).
This
illustrated,
via
rare
case
physician
very
high
hypobetalipoproteinemia.
She
experiences
twice
considerable
(+32%,
+
28mg/dL,
67nmol/L)
higher
equivalent
(138mg/dL
versus
123mg/dL)
mediterranean
diet,
low
in
SFA.
A
reasonable
SFA
intake,
despite
causing
marginal
increase,
be
advisable
patients
who
need
personalized
recommendations.
Language: Английский
Lipoprotein(a): Are we ready for large-scale clinical trials?
Shiyue Zheng,
No information about this author
Guangming Fang,
No information about this author
Jie Du
No information about this author
et al.
International Journal of Cardiology,
Journal Year:
2024,
Volume and Issue:
410, P. 132236 - 132236
Published: June 5, 2024
Language: Английский
Tele-Pulmonary Rehabilitation and Mediterranean-like Lifestyle, Adjunctively to Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients: Effects in Fitness and Oxidative Indicators
Applied Sciences,
Journal Year:
2024,
Volume and Issue:
14(18), P. 8424 - 8424
Published: Sept. 19, 2024
Obstructive
sleep
apnea
(OSA),
often
overlooked
by
clinicians,
may
lead
to
negative
outcomes
if
left
untreated.
In
this
study,
we
examined
the
efficacy
and
efficiency
of
a
12-week
unsupervised
tele-rehabilitation
program
in
OSA
patients
focused
on
potential
changes
their
fitness
indicators
oxidative
status.
Forty
were
allocated
into
two
groups:
CPAPgroup
(AHI
52.0
±
31.5
events/h;
age,
49.7
9.4
years;
BMI,
32.1
7.6
kg/m2;
control
group)
versus
non-CPAPgroup
38.2
21.5
49.3
10.7
32.3
5.1
intervention
group;
personalized
recommendations
for
nutrition—based
Mediterranean
diet—and
exercise
programs).
Measurements
included
anthropometric
characteristics
body
composition
through
whole-body
bioelectrical
impedance
analysis.
addition,
participants
underwent
blood
sampling
reactive
oxygen
metabolites’
levels
(d-ROM),
plasma
antioxidant
capacity
(PAT),
Lipoprotein
(a)
(Lp(a)),
as
well
6
min
walk
test
(6MWT).
Statistically
significant
differences
detected
both
groups
(CPAPgroup
non-CPAPgroup)
after
12
weeks
between
Lp(a)
(−32.2
25.5%,
p
=
0.021
−17.7
16.3%,
0.034)
6MWT
(16.6
9.3%,
<
0.001
7.5
6.6%,
0.002).
ΔNRO2
(oxygen
saturation
difference
nadir
during
resting
awake)
was
significantly
associated
with
d-ROMs
(p
0.045),
mean
arterial
pressure
0.024),
chest
circumference
maximal
inhalation
exhalation
(Δchest,
0.001).
To
conclude,
lifestyle
interventions
tele-exercise-rehabilitation
pulmonary
programs
Mediterranean-like
diet
serve
adjunctive-to-CPAP
therapeutic
elements.
Language: Английский